Mast cell infiltration is involved in renal interstitial fibrosis in a rat model of protein-overload nephropathy

Kidney and Blood Pressure Research

Volumn 33, Issue 3, 2010, Pages 240-248

  Li, Ying ^a   Zhou, Letiang ^a   Liu, Fuyou ^a   Peng, Youming ^a   Li, Jun ^a   Sun, Lin ^a   Duan, Shaobin ^a   Ling, Guanghui ^a   Chen, Xin ^a   Jiang, Wenling ^a   Xia, Yuncheng ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Mast cell; Protein overload nephropathy; Renal interstitial fibrosis; Stem cell factor; Transforming growth factor 1

Indexed keywords

CHYMASE; STEM CELL FACTOR; TOLONIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA1; TRYPTASE; BOVINE SERUM ALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL INFILTRATION; CONTROLLED STUDY; FIBROSING ALVEOLITIS; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; MALE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; STAINING; ANIMAL; BOVINE; CHEMICALLY INDUCED; DISEASE MODEL; FIBROSIS; INTERSTITIAL NEPHRITIS; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CATTLE; DISEASE MODELS, ANIMAL; FIBROSIS; MALE; MAST CELLS; NEPHRITIS, INTERSTITIAL; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; SERUM ALBUMIN, BOVINE;

EID: 77954210547     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000317102     Document Type: Article

References (27)

1. Hewitson TD: Renal tubulointerstitial fibrosis: common but never simple. Am J Physiol Renal Physiol 2009; 296:F1239-F1244.
2. Rodriguez-Iturbe B, Johnson RJ, Herrera-Acosta J: Tubulointerstitial damage and progression of renal failure. Kidney Int Suppl 2005; 99:S82-S86.
3. Liu FY, Li Y, Peng YM, et al: Relationship between clinical predictors and tubulointerstitial damage in adult-onset primary nephrotic syndrome. Arch Med Res 2006; 37: 981-986.
4. Strutz FM: EMT and proteinuria as progression factors. Kidney Int 2009; 75: 475-481.
5. Nonaka Takahashi S, Fujita T, Takahashi T, et al: TGF- 1 and CTGF mRNAs are correlated with urinary protein level in IgA nephropathy. J Nephrol 2008; 21: 53-63.
6. Blank U, Essig M, Scandiuzzi L, et al: Mast cells and inflammatory kidney disease. Immunol Rev 2007; 217: 79-95.
7. Da Silva CA, Reber L, Frossard N: Stem cell factor expression, mast cells and inflammation in asthma. Fundam Clin Pharmacol 2006; 20: 21-39.
8. Holdsworth SR, Summers SA: Role of mast cells in progressive renal diseases. J Am Soc Nephrol 2008; 19: 2254-2261.
9. Li Y, Liu FY, Peng YM, et al: Mast cell, a promising therapeutic target in tubulointerstitial fibrosis. Med Hypotheses 2007; 69: 99-103.
10. Nilsson G, Butterfield JH, Nilsson K, Siegbahn A: Stem cell factor is a chemotactic factor for human MCs. J Immunol 1994; 153: 3717-3723.
11. Gruber BL, Marchese MJ, Kew RR: Transforming growth factor- 1 mediates mast cell chemotaxis. J Immunol 1994; 152: 5860-5867.
12. Liu FY, Li Y, Peng YM, et al: Norcantharidin ameliorates proteinuria, associated tubulointerstitial inflammation and fibrosis in protein overload nephropathy. Am J Nephrol 2008; 28: 465-477.
13. D'Amico G, Ferrario F, Rastaldi MP: Tubulointerstitial damage in glomerular diseases: its role in the progression of renal damage. Am J Kidney Dis 1995; 26: 124-132.
14. Hwang M, Kim HJ, Noh HJ, et al: TGF- 1 siRNA suppresses the tubulointerstitial fibrosis in the kidney of ureteral obstruction. Exp Mol Pathol 2006; 81: 48-54.
15. Ninichuk V, Khandoga AG, Segerer S, et al: The role of interstitial macrophages in nephropathy of type 2 diabetic db/db mice. Am J Pathol 2007; 170: 1267-1276.
16. Ko GJ, Boo CS, Jo SK, et al: Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion-induced acute kidney injury. Nephrol Dial Transplant 2008; 23: 842-852.
17. Okö K, Stachura J: Increased mast cell density in renal interstitium is correlated with relative interstitial volume, serum creatinine and urea especially in diabetic nephropathy but also in primary glomerulonephritis. Pol J Pathol 2007; 58: 193-197.
18. Welker P, Krämer S, Groneberg DA, et al: Increased mast cell number in human hypertensive nephropathy. Am J Physiol Renal Physiol 2008; 295:F1103-F1109.
19. Sakamoto-Ihara T, Suzuki Y, Kurusu A, et al: Possible involvement of mast cells in renal fibrosis in patients with IgA nephropathy. Inflamm Res 2007; 56: 421-427.
20. Togawa H, Nakanishi K, Shima Y, et al: Increased chymase-positive mast cells in children with crescentic glomerulonephritis. Pediatr Nephrol 2009; 24: 1071-1075.
21. Zandi-Nejad K, Eddy AA, Glassock RJ, et al: Why is proteinuria an ominous biomarker of progressive kidney disease? Kidney Int Suppl 2004; 92:S76-S89.
22. Silva GE, Costa RS, Ravinal RC, et al: Mast cells, TGF- 1 and-SMA expression in IgA nephropathy. Dis Markers 2008; 24: 181-190.
23. Okayama Y, Kawakami T: Development, migration, and survival of mast cells. Immunol Res 2006; 34: 97-115.
24. Huang B, Lei Z, Zhang GM, et al: SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood 2008; 112: 1269-1279.
25. El Kossi MM, Haylor JL, Johnson TS, et al: Stem cell factor in a rat model of serum nephrotoxic nephritis. Nephron Exp Nephrol 2008; 108:e1-e10.
26. Jones SE, Kelly DJ, Cox AJ, et al: Mast cell infiltration and chemokine expression in progressive renal disease. Kidney Int 2003; 64: 906-913.
27. Murphy M, Docherty NG, Griffin B, et al: IHG-1 amplifies TGF- 1 signaling and is increased in renal fibrosis. J Am Soc Nephrol 2008; 19: 1672-1680.